CytomX Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.63
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
7
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.31
|
-0.35
|
-0.04
|
-12.90%
|
|
2022-06-30
|
-0.36
|
-0.37
|
-0.01
|
-2.78%
|
|
2022-03-31
|
-0.36
|
-0.37
|
-0.01
|
-2.78%
|
|
2021-12-31
|
-0.28
|
-0.40
|
-0.12
|
-42.86%
|
|
2021-09-30
|
-0.31
|
-0.35
|
-0.04
|
-12.90%
|
|
2021-06-30
|
-0.32
|
-0.30
|
0.02
|
6.25%
|
|
2021-03-31
|
-0.35
|
-0.26
|
0.09
|
25.71%
|
|
2020-12-31
|
-0.50
|
-0.32
|
0.18
|
36.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.09
|
|
2021-12-31
|
-1.31
|
|
2020-12-31
|
-0.72
|
|
2019-12-31
|
-2.25
|
|
2018-12-31
|
-2.00
|
|
2017-12-31
|
-1.17
|
|
2016-12-31
|
-1.62
|
|
2015-12-31
|
-14.65
|